Abstract. RAB25 belongs to the Rab family of small GTPases and is implicated in the development of various types of human cancer. To evaluate the role of RAB25 in ovarian cancer, RAB25 was knocked down by siRNA in HEY and ES-2 human ovarian cancer cells. Autophagy, cell growth and cell apoptosis were evaluated. The results showed that knockdown of RAB25 increased acidic vesicle organelles and GFP-microtubule-associated protein 1 light chain 3 punctate fluorescence in ovarian cancer cells. Autophagy that promoted by knockdown of RAB25 was not observed in cells where the ERK1/2 signaling pathway had been inhibited by U0126. Knockdown of RAB25 reduced cell cycle progression and cell growth. Apoptosis of ovarian cancer cells could be induced by knockdown of RAB25. These results support the tumorigenic role of RAB25 in ovarian cancer cells.
Introduction
Ovarian cancer is the second most common gynecological malignancy and affects more than 200,000 women worldwide each year. The symptoms of ovarian cancer are non-specific and therefore two-thirds of cases are not diagnosed until the later stages (1) . Aggressive surgical reduction and new chemotherapeutic agents have improved the prognosis of advanced ovarian cancer (2, 3) ; however, the 5-year survival rate remains low in more than half of diagnosed women (4) (5) (6) (7) (8) . Therefore, it is critical to investigate the biological behavior of ovarian cancer cells and identify new prognostic factors and therapeutic targets.
RAB25 belongs to the Rab family of small GTPases, which regulates various aspects of membrane recycling and trafficking to the plasma membrane (9) . Unlike the other members of the ubiquitously expressed RAB11 sub-family, RAB25 expression is restricted to epithelial tissue (10) and is correlated with several epithelial cancers. Overexpression of RAB25 has been reported in liver (10) and bladder cancer (11) and is also associated with the aggressive behavior of ovarian and breast cancers (12, 13) . RAB25 has been implicated in the promotion of cell proliferation, evasion of apoptosis and acceleration of in vivo tumor growth in ovarian cancer (12, 14, 15) .
Autophagy refers to the process of autodigestion in which the cell's own components are degraded and recycled by the lysosomal machinery (16) . Autophagy is induced by starvation, hypoxia and high temperature. Through the partial digestion of cell components, autophagy provides nutrients that are necessary to maintain cell viability and prolonged survival (17) . However, autophagy may result in the destruction of vital organelles, leading to cell death (18) . Previous studies have suggested a correlation between the decline in autophagic activity and tumorigenesis (19, 20) , while chemotherapeutic agents stimulate autophagic cell death (21, 22) .
The role of RAB25 in ovarian cancer cells was evaluated in vitro. The present study reveals that knockdown of RAB25 by siRNA promoted autophagy through activation of the ERK1/2 signaling pathway. It indicated that knockdown of RAB25 resulted in the inhibition of cell proliferation and the induction of apoptosis. These results support the tumorigenic role of RAB25 in ovarian cancer cells.
Materials and methods
Cell culture and treatment. HEY and ES-2 human ovarian cancer cell lines (donated by the University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA) were grown in RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin and 10% FBS (Hyclone, Logan, UT, USA) in a humidified Acridine orange staining assay. The formation of acidic vesicle organelles (AVOs) is a characteristic of autophagic cell death (23) . To stain AVOs in cells, acridine orange (Sangon) was added into the medium at a final concentration of 1 µg/ml. The cells were incubated at 37˚C for 15 min and then harvested with trypsin and immediately analyzed on a flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). AVOs were quantified using the Cy5-Phycoerythrin emission (PE) signal detector.
GFP-microtubule-associated protein 1 light chain 3 (LC3)
transfection. LC3 is involved in microtubule assembly and autophagy. Endogenous LC3 is processed into LC3-I and then lipidated to LC3-II. LC3-II is associated with the autophagosome membrane and thus regarded as a promising marker of autophagy. Ovarian cancer cells were transfected with siRNA as described previously on day 1 and then transfected with pEGFP-LC3 plasmid (kindly provided by N. Mizushima and T. Yoshimori, National Institute for Basic Biology, Okazaki, Japan) on day 2. pEGFP-LC3 was added at a final concentration of 1.6 µg/ml using Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions. Following incubation for 6 h, cells were replenished with serum-free Opti-MEM for 12 h. The resultant cells were fixed with 95% ethanol for microscopic analysis. Statistical analysis. Data are expressed as the mean ± SD obtained from three individual experiments. Statistical differences between the control and treatment groups were determined by one-way ANOVA followed by Dunnet's test. P<0.05 was considered to indicate statistically significant differences. Representative images from western blotting and microscope analysis are shown.
Results

RAB25 siRNA downregulates the expression of RAB25 and increases the expression of pERK1/2 in ovarian cancer cells.
HEY and ES-2 ovarian cancer cells were assessed for the knockdown efficiency of RAB25 siRNA 24 h after transfection. Transfection with siRab resulted in a 75.1% reduction of RAB25 mRNA levels in HEY cells (P<0.01) and a 70.7% reduction in ES-2 cells (P<0.01) compared with siNon-treated cells (Fig. 1A) . The RAB25 protein expression in transfected cells was consistent with the transcription assay results (Fig. 1B and C) . These data revealed that RAB25 was effectively downregulated by siRab in the ovarian cancer cell lines used in this study.
Knockdown of RAB25 increases AVOs through the ERK1/2 signaling pathway in ovarian cancer cells.
To investigate whether RAB25 is involved in autophagy, the level of AVOs was examined in transfected ovarian cancer cells. The percentages of cells with AVOs in siRab-transfected cells were significantly higher Fig. 2A ). These data suggest that knockdown of RAB25 promotes autophagy in ovarian cancer. The ERK1/2 signaling pathway plays a role in regulating autophagy (24) (25) (26) (27) and therefore the effect of RAB25 siRNA on the ERK signaling pathway in ovarian cancer cells was examined. Compared with siNon, transfection with siRab increased the expression of phospho-ERK1/2 (Fig. 2B ). The transfected cells were then treated with U0126, a MEK 1 inhibitor, to test whether the ERK1/2 signaling pathway is involved in Increased AVOs were noted in the untreated siRab-transfected cells but not in the U0126-treated cells ( Fig. 2A) , suggesting that the effect of RAB25 on autophagy is mediated through the ERK1/2 signaling pathway. Knockdown of RAB25 upregulated autophagic proteins in ovarian cancer cells. Beclin 1, an autophagy-related protein, is required for the initiation of autophagy. Knockdown of RAB25 increased Beclin 1 expression and conversion of LC3-I to LC3-II. These changes were reversed by U0126 treatment (Fig. 4) . These findings further confirm that RAB25 regulates autophagy through the ERK1/2 signaling pathway.
Knockdown of RAB25 increased GFP-
Knockdown of RAB25 inhibited cell growth in ovarian cancer cells.
To determine whether knockdown of RAB25 impacted ovarian cancer cell growth, the proliferation of transfected HEY and ES-2 cells was evaluated. Transfection with siRab reduced cell growth by 25.9% in HEY cells (P<0.01) and 36.6% in ES-2 cells (P<0.01) compared with siNon (Fig. 5A) . These results were further confirmed by cell cycle analysis, which revealed that siRab transfection significantly increased the proportion of cells in G0/G1 phase (P<0.05) and decreased the proportion of cells entering S phase (P<0.05) compared with siNon (Fig. 5B ). Protein expression of cyclin D1, a marker of G1/S progression and cyclin B1, a marker of G2/M progression, were analyzed by western blotting. The data indicated that siRab-transfected ovarian cancer cells exhibited lower expression of cyclin D1 and cyclin B1 compared with siNon ( Fig. 5C ). A B C cells. Since survivin plays a critical role in cell survival and apoptosis, the expression of survivin was analyzed, which revealed a reduction following siRab transfection. The level of cleaved caspase-3, a marker of apoptosis, was also increased by siRab transfection (Fig. 6C ).
Knockdown of RAB25 induced apoptosis in ovarian cancer
Discussion
Cancer cell transformation involves alterations in cell shape and behavior. Cancers of epithelial origin arise from a loss of polarized epithelial monolayer and adoption of migratory behaviors that lead to invasion (28) . RAB25 regulates the membrane-trafficking system that changes epithelial cell polarity and aids the localization of integrin-recycling vesicles that enhance invasive ability (29) , suggesting a role for RAB25 in tumorigenesis.
Overexpression of RAB25 has been reported in ovarian cancer and is associated with decreased survival rates (12) . Studies on ovarian cancer have demonstrated that RAB25 facilitates cell proliferation and anti-apoptotic effects (12, 14, 15) . In agreement with previous studies, these results indicated that knockdown of RAB25 in ovarian cancer cells inhibited cell growth and induced apoptosis. Studies on RAB25 expression in other types of cancer, however, have shown mixed results. RAB25 has been reported to be overexpressed in liver and bladder cancer, but downregulated in colon cancers (28) . RAB25 expression has been associated with invasiveness in breast cancer, but loss of expression has also been reported in some breast cancer tissue (30, 31) . The role of RAB25 in tumorigenesis may be tissue-specific and requires further elucidation.
Autophagy occurs after nutrient deprivation or following chemotherapy in cancer cells (32, 33) . The impact of autophagy on cancer progression is controversial and whether autophagic activities in cells actually cause death or are a survival mechanism remains unclear. However, excessive autophagy damages the cell. In the present study, knockdown of RAB25 promoted autophagy, suggesting that suppression of RAB25 was stressful to ovarian cancer cells and induced programmed cell death mechanisms. This result implies that RAB25 is a new candidate for targeted cancer therapy.
Previous studies have demonstrated a correlation between the MAPK/ERK pathway and autophagy (24) (25) (26) (27) . Prolonged activation and cytoplasmic sequestration of ERK1/2 induce autophagy (34) (35) (36) (37) . In this study, knockdown of RAB25 with siRNA activated the ERK1/2 pathway and promoted autophagy. Blocking ERK1/2 concurrently inhibited autophagy, suggesting that the ERK signaling pathway mediates the effects of RAB25 on autophagy in ovarian cancer cells.
In conclusion, knockdown of RAB25 promoted autophagy, inhibited cell proliferation and induced apoptosis in ovarian 
